IgAN
American Society of Nephrology (ASN) 2020
Virtual
October 22-25, 2020
Abstract
24-Week Interim Analysis of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria
Barratt J, et al.